Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Pediatr ; 119(1 Pt 1): 46-50, 1991 Jul.
Article in English | MEDLINE | ID: mdl-2066858

ABSTRACT

We report a controlled study of intellectual outcome in 16 children with maple syrup urine disease (MSUD) that compares the outcome of MSUD diagnosed after symptoms became apparent with that of MSUD diagnosed prospectively and in unaffected siblings and parents. The mean IQ (+/- SD) score in the children with classic MSUD was 78 +/- 24; however, there were two discrete groups: one with normal IQ (greater than 84) whose MSUD had been diagnosed at a mean age of 3.5 days and a second group, with IQ below normal, whose MSUD was diagnosed at a mean of 10 days of age. Affected children treated presymptomatically had higher IQ scores than their affected siblings treated when their disease was symptomatic. Multiple regression analysis indicated that the important influences on IQ were age at the time of diagnosis and long-term metabolic control; control at the time of testing also might have affected performance. The mean score of unaffected siblings was 92 +/- 5 and the mean parental IQ was 83 +/- 9. The mean IQ scores of children with variant MSUD, 97 +/- 4, was similar to that of their parents, 103 +/- 6. This study was not longitudinal and thus could not identify subtle developmental learning problems. We conclude that early and meticulous treatment of MSUD can result in intellectually normal children.


Subject(s)
Intelligence , Maple Syrup Urine Disease , Adult , Child , Child, Preschool , Female , Humans , Infant , Intellectual Disability/etiology , Intelligence Tests , Leucine/blood , Male , Maple Syrup Urine Disease/complications , Maple Syrup Urine Disease/diagnosis , Prognosis , Prospective Studies , Regression Analysis
2.
J Pediatr ; 113(6): 1022-7, 1988 Dec.
Article in English | MEDLINE | ID: mdl-3193307

ABSTRACT

We report four patients with methylmalonic acidemia who developed acute extrapyramidal disease after metabolic decompensation. The neurologic findings resulted from bilateral destruction of the globus pallidus with variable involvement of the internal capsules. This complication was unrelated to a specific gene defect responsible for methylmalonic acidemia or to cyanocobalamin administration. These lesions constitute a "metabolic stroke," probably because of the accumulation of toxic organic acid metabolites, because they cannot be accounted for by hypoxemia or vascular insufficiency.


Subject(s)
Amino Acid Metabolism, Inborn Errors/complications , Basal Ganglia Diseases/pathology , Brain Diseases, Metabolic/pathology , Cerebrovascular Disorders/pathology , Globus Pallidus/pathology , Malonates/blood , Methylmalonic Acid/blood , Adolescent , Amino Acid Metabolism, Inborn Errors/pathology , Atrophy , Cerebral Cortex/pathology , Child, Preschool , Female , Humans , Male , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL